HSA Approval

GLIOTEM 20 CAPSULE 20 MG

Approval Number

SIN15641P

Drug Name

Product Name

GLIOTEM 20 CAPSULE 20 MG

Approval Date

March 1, 2019

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Regulatory Information

Registrant

RANBAXY (MALAYSIA) SDN. BHD.

Licence Holder

RANBAXY (MALAYSIA) SDN. BHD.

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

CAPSULE

Route of Administration

ORAL

Medical Information

ATC Code

L01AX03

ATC Item Name

temozolomide

Manufacturer Information

Pharmaceutical Manufacturer

RANBAXY (MALAYSIA) SDN. BHD.

Manufacturers

Sun Pharmaceutical Industries Limited.

Active Ingredients

Ingredient Name

Temozolomide

Strength

20.000 mg

Drug MonographTemozolomide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

GLIOTEM 20 CAPSULE 20 MG - HSA Approval | MedPath

AI-Powered Research

Premium Access

GLIOTEM 20 CAPSULE 20 MG

Regulatory Information

Formulation Information

Medical Information

Manufacturer Information

Active Ingredients

MedPath

Product

Company

Legal